Live tape
Top 8, mentions 7d7,437META2,242 mentions▲ +0.06GOOGL1,494 mentions▲ +0.02NVDA782 mentions▲ +0.09MUSE663 mentions▲ +0.07MSFT600 mentions▲ +0.06SPY565 mentions▲ +0.05QQQ552 mentions▲ +0.08TSLA539 mentions▲ +0.06

Equity · Healthcare

OPCH

Option Care Health, Inc. · NasdaqGS

$21.74 −1.20% vs prior close Finazon · prior-day close, indicative (IEX-derived, not the official close) · Jul 17, 2026
Price · Chart
Our own end-of-day closes 13 sessions
$22.5 $20.5 30 Jun 17 Jul

The line runs $21 on 30 June through $21.74 on 17 July, on a scale from $20.5 to $22.5. Days the market did not trade hold the previous close, flat.

Track this symbol on TradingView

The chart above plots the price of OPCH over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 13 sessions over that window: $21 on 30 June 2026 through $21.74 on 17 July 2026.

Market cap $3.4B
P/E (TTM) 17.0
52-week range $19.60 – $36.60
Avg volume 532.7K

Finazon · prior-day close, indicative (IEX-derived, not the official close) · valuation computed from SEC EDGAR filings · as of Jul 17, 2026

OPCH insider trades

SEC Form 4

OPCH has no Form 4 filing in the last 90 days, so there is no summary for that window. The most recent filings we hold are below, the newest dated 3 November 2025.

Date Insider Type Shares Value
03 Nov 2025 KRAEMER HARRY M JANSEN JR Buy 38,000 $987K
09 Sep 2025 Wright Norman L. Buy 3,411 $100K

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
01 Oct 2025 Sethna Meenal Chief Financial Officer Award 55,067

OPCH reported financials

SEC EDGAR XBRL

OPCH reported revenue of $5.6B for the fiscal year ended 31 Dec 2025. Net income over the same period was $207.6M.

Figure Reported Period
Revenue $5.6B 31 Dec 2025 fiscal year
Net income $207.6M 31 Dec 2025 fiscal year
Diluted EPS $1.27 31 Dec 2025 fiscal year
Total assets $3.4B 31 Mar 2026 at period end
Total equity $1.4B 31 Mar 2026 at period end

Source: SEC EDGAR XBRL company facts · latest period ended 31 Mar 2026

OPCH earnings

SEC EDGAR
Date Period EPS Revenue
31 Mar 2026 Q1 2026 $0.29 $1.35B
31 Dec 2025 FY 2025 $1.27 —
30 Sep 2025 Q3 2025 $0.32 —
30 Jun 2025 Q2 2025 $0.31 —
31 Mar 2025 Q1 2025 $0.28 $1.33B
31 Dec 2024 FY 2024 $1.23 $5.00B
30 Sep 2024 Q3 2024 $0.31 —
30 Jun 2024 Q2 2024 $0.30 —

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

OPCH institutional holders

SEC Form 13F

10 of the 45 institutional funds we track reported a OPCH position for the quarter ended 30 Jun 2026 — a combined $157.0M; the latest of those filings landed 02 Sep 2026.

Fund Action Shares Value
Millennium Management Added +59.6% shares 2,618,869 $54.9M
Point72 Asset Management Added +219.9% shares 1,800,244 $37.8M
Citadel Advisors Trimmed −53.8% shares 1,633,556 $34.3M
GAMCO Investors Held (±25%) +2.8% shares 312,560 $6.6M
D. E. Shaw & Co. Added +88.7% shares 284,168 $6.0M
Tudor Investment Corp New position 240,413 $5.0M
Man Group Held (±25%) −18.5% shares 220,746 $4.6M
AQR Capital Management Added +158.9% shares 170,159 $3.6M
Bridgewater Associates New position 110,288 $2.3M
Two Sigma Investments Trimmed −46.9% shares 97,596 $2.0M

Source: SEC EDGAR 13F filings

OPCH fails-to-deliver

SEC CNS data

On 31 Aug 2026, 669 shares of OPCH failed to deliver (about $16K).

Settlement date Shares failed Notional % of shares out
31 Aug 2026 669 $16K <0.001%
14 Aug 2026 80 $2K <0.001%

Source: SEC fails-to-deliver (CNS) data